Novel combination treatment for acute myeloid leukemia (aml)
US-2023381215-A1 · Nov 30, 2023 · US
This page is not indexed by search engines while we improve data quality.
Packman Kathryn E patents
Packman Kathryn E is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Packman Kathryn E |
| Total patents | 12 |
| First publication | Jun 11, 2015 |
| Latest publication | Nov 30, 2023 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibitors of bruton's tyrosine kinase and methods of their use
US-2023013755-A1 · Jan 19, 2023 · US
Novel combination treatment for acute myeloid leukemia (aml)
US-2022031726-A1 · Feb 3, 2022 · US
Antibodies specific for DR5 and methods of use
US-11214622-B2 · Jan 4, 2022 · US
Novel combination treatment for acute myeloid leukemia (aml)
US-2020253999-A1 · Aug 13, 2020 · US
Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use
US-2019062453-A1 · Feb 28, 2019 · US
Combination treatment for acute myeloid leukemia (AML)
US-9956243-B2 · May 1, 2018 · US
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
US-9926379-B2 · Mar 27, 2018 · US
Novel combination treatment for acute myeloid leukemia (aml)
US-2016303158-A1 · Oct 20, 2016 · US
Combination of ro5503781 and capecitabine for cancer therapy
US-2016129033-A1 · May 12, 2016 · US
Recent patents
Latest publications not already listed above.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 8 |
| Roche Glycart Ag | 3 |
| Janssen Pharmaceutica Nv | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 12 |
| A61P35/02 | 10 |
| A61P43/00 | 10 |
| A61K31/7068 | 8 |
| A61K31/40 | 8 |